Reena Mehra1, Kingman P Strohl. 1. Center for Sleep Disorders Research, Louis Stokes DVA Medical Center, Case Western Reserve University Cleveland, OH, USA. mehrar@ameritech.net
Abstract
OBJECTIVES: The purpose of the study was to verify whether minimal concern is warranted in regard to serious adverse effects in the sleep laboratory. DESIGN: A prospective multicenter study PARTICIPANTS: Three scoring teams for 17 sleep laboratories. METHODS: Reports of adverse events occurring during polysomnography or identified upon scoring a study were collected over an 18-month time period. Incidence of mortality and adverse events were evaluated using a binomial distribution based on the Bernoulli process. RESULTS: Of 16,084 studies, the mortality rate during or 2 weeks after an adverse event, as noted, was 0.006%, and the overall rate of adverse events was 0.35%. CONCLUSIONS: Adverse event rates are low; however, procedures for handling medical emergencies or adverse events during or after polysomnography are prudent, and those studies performed for research should include preparedness for the possibility of adverse events.
OBJECTIVES: The purpose of the study was to verify whether minimal concern is warranted in regard to serious adverse effects in the sleep laboratory. DESIGN: A prospective multicenter study PARTICIPANTS: Three scoring teams for 17 sleep laboratories. METHODS: Reports of adverse events occurring during polysomnography or identified upon scoring a study were collected over an 18-month time period. Incidence of mortality and adverse events were evaluated using a binomial distribution based on the Bernoulli process. RESULTS: Of 16,084 studies, the mortality rate during or 2 weeks after an adverse event, as noted, was 0.006%, and the overall rate of adverse events was 0.35%. CONCLUSIONS: Adverse event rates are low; however, procedures for handling medical emergencies or adverse events during or after polysomnography are prudent, and those studies performed for research should include preparedness for the possibility of adverse events.
Authors: Yüksel Peker; Jan Hedner; Jeanette Norum; Holger Kraiczi; Jan Carlson Journal: Am J Respir Crit Care Med Date: 2002-07-15 Impact factor: 21.405
Authors: Naresh M Punjabi; John D Sorkin; Leslie I Katzel; Andrew P Goldberg; Alan R Schwartz; Philip L Smith Journal: Am J Respir Crit Care Med Date: 2002-03-01 Impact factor: 21.405